Rafael Henrique | Lightrocket | Getty Images Britain’s GSK on Wednesday became the latest pharmaceutical firm to commit bumper investment into the U.S., as President Donald Trump is in the U.K. for a three-day state visit. The drug maker committed to investing at least $30 billion in U.S. research and developing (R&D) and manufacturing over the coming five years. The …
Read More »
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hey, good morning. Today, we see CBER suspend the license for a chikungunya vaccine, look at a push to recall a safety and efficacy study for the antidepressant Paxil, and more. FDA pulls license for chikungunya vaccine The Food and …
Read More »Hengrui Shares Jump on GSK Deal Worth Up To $12 Billion Bloomberg GSK’s $500M Mega-Deal Unlocks 12 New Medicines: Major COPD Breakthrough in Pipeline Stock Titan Jiangsu Hengrui Pharma stock spikes 10% to 4-year high on drug development deal with GSK – here’s what the company does Mint GSK pays $500M upfront for rights to series of Hengrui drugs statnews.com GSK strengthens COPD offering …
Read More »